Type 2 diabetes. Diabetes mellitus
Conditions
Interventions
Intervention 1: case group:no treatment. Intervention 2: Participants of the case group were asked to consume 4 of cornus mas twice a day after the lunch and dinner.
Placebo
Treatment - Drugs
Participants of the case group were asked to consume 4 of cornus mas twice a day after the lunch and dinner
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Type 2 diabetes mellitus patients (according to America Diabetes Association ADA); glycosylated hemoglobin levels above 7% and less than 12%; subjects between the ages 18 to 80 years; No alcohol and other drug abuse; Does not change the dose of anti-diabetic medication within 1 month Exclusion criteria: Individuals with a history of diseases; liver and kidney; with the medication use affecting blood sugar levels; pregnant and breastfeeding; hypersensitivity to the drug used in this study; the incidence of diabetic foot ulcers; heart disease, severe systolic blood pressure = 180 and / or pressure diastolic = 110
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS level. Timepoint: Baseline and after 6 weeks. Method of measurement: By autoanalyzer.;Hgb A1C level. Timepoint: Baseline and after 6 weeks. Method of measurement: By autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine. Timepoint: Before and after 6 weeks. Method of measurement: By autoanalyzer.;Alanine transaminase (ALT). Timepoint: Before and after 6 weeks. Method of measurement: By autoanalyzer.;Aspartate transaminase (AST). Timepoint: Before and after 6 weeks. Method of measurement: By autoanalyzer.;Length. Timepoint: Before and after 6 weeks. Method of measurement: meter.;Weight. Timepoint: Before and after 6 weeks. Method of measurement: Scale. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed